Sherif El-Refai

394 posts

Sherif El-Refai banner
Sherif El-Refai

Sherif El-Refai

@smelrefai

Precision Medicine Industry Professional PharmD, PhD, MBA https://t.co/rvB88fWiGG… https://t.co/Zn4El23ula…

Katılım Nisan 2012
431 Takip Edilen71 Takipçiler
Sherif El-Refai retweetledi
Mohamed E. Salem, MD, FASCO
Mohamed E. Salem, MD, FASCO@SalemGIOncDoc·
It was a great honor to do this alongside amazing scientists & collaborators @JeanneTie @agrothey @TGeorgeMD @TaberneroJosep & Dr. Van Cutsem.Hopefully this will inform the design of the next generation #clinicaltrials #ASCO #ASCO21 @TempusLabs @OncoAlert meetinglibrary.asco.org/record/197518/…
A.n.n.@fireflyann

MORE w/ #ASCO21 abstract released today: Landscape of KRASG12C, associated genomic alterations, and interrelation with immuno-oncology (IO) biomarkers. Relationship to high TMB and PD-L1 overexpression. #Colorectal #CRCSM @agrothey @JeanneTie meetinglibrary.asco.org/record/197518/…

English
1
3
12
0
Sherif El-Refai retweetledi
Tempus
Tempus@TempusAI·
Don’t miss our Founder and CEO @lefkofsky unveil the latest Tempus product and a breakthrough in healthcare AI during this first-ever demo at the #JPM21 Annual Healthcare Conference this Monday at 2:45 p.m. CST. Not attending? Save this link to listen in: tempus.co/JPM21.
Tempus tweet media
English
0
9
19
0
Sherif El-Refai retweetledi
Tempus
Tempus@TempusAI·
This #BreastCancerAwarenessMonth, we’re pleased to share our paper showing longitudinal real-world data from breast cancer patients in the Tempus database mirrors the overall U.S. breast cancer population, showcasing a valuable tool for #RWE generation: bit.ly/3c47KLS.
Tempus tweet media
English
0
5
8
0
Sherif El-Refai retweetledi
Tempus
Tempus@TempusAI·
It’s great to see @TIME shine a light on how liquid biopsies can add genetic insights to further personalize cancer care. Our xF liquid biopsy test is a good option for clinicians seeking a non-invasive genomic test for their patients. Read more from TIME: bit.ly/365xiaQ
English
0
6
8
0
Sherif El-Refai retweetledi
Tempus
Tempus@TempusAI·
Tempus’ VP, Head of Translational Medicine Nike Beaubier, MD and Scientific and Medical Writer Namratha Sastry, PhD spoke with @cancercommons to discuss how we use precision oncology to derive personalized diagnostics and therapeutic insights: bit.ly/3hQPkQT.
English
1
6
11
0
Sherif El-Refai retweetledi
Tempus
Tempus@TempusAI·
We are honored to be named on this year’s @CBinsights’ Digital Health 150 list, joined by some of the most promising private digital health companies in the world that are transforming #healthcare with the use of technology. View the full list here: bit.ly/3fNAE3m.
English
1
6
9
0
Sherif El-Refai retweetledi
CNBC Disruptors
CNBC Disruptors@CNBCDisruptors·
COMING UP: Former Groupon CEO Eric @Lefkofsky joins Squawk Box to discuss the pace at which his latest endeavor, @TempusLabs, is growing in the wake of the pandemic. The genomic-sequencing company ranked No. 6 on this year's #Disruptor50 list. Tune in! 📺
CNBC Disruptors tweet media
English
0
2
6
0
Sherif El-Refai retweetledi
Eric J. Small, MD, FASCO
Eric J. Small, MD, FASCO@ASCOPres·
#ASCO20 really is united! Phenomenal participation & engagement ➡️ over 3.1 million page views and counting! We will share final numbers shortly after the meeting. 👏
English
1
18
112
0
Sherif El-Refai retweetledi
Tempus
Tempus@TempusAI·
By combining clinical and molecular data, Tempus offers comprehensive reports that share actionable treatment options tailored to your patients. Learn more about how Tempus|X supports you in providing personalized cancer care and how to order a broad-panel genomic sequencing test
English
3
8
62
0
Sherif El-Refai retweetledi
Eric Lefkofsky
Eric Lefkofsky@lefkofsky·
For #ASCO20, @TempusLabs published an abstract on our forthcoming #HRD test— a valuable tool that uses #genomicsequencing to help oncologists identify patients that may benefit from PARP inhibitor therapies.
Tempus@TempusAI

Explore the #ASCO20 abstract on our forthcoming #HRD test that aids physicians in identifying patients that are candidates for PARP inhibitor therapies, and learn more on HRD testing that integrates #wholetranscriptome data to support treatment strategies: bit.ly/3csdn66

English
1
6
15
0
Sherif El-Refai retweetledi
Tempus
Tempus@TempusAI·
We believe that data should be shared among the healthcare community, advancing the critical research being done to improve patient outcomes. That’s why we support National Cancer Research Month and its effort to show how cancer #ResearchSavesLives. #NCRM20 #NCRM @AACR
Tempus tweet media
English
0
3
8
0

Keşfet

@TempusLabs @JCOPO_ASCO @ASCO @Twitter @OncoAlert @JeanneTie @agrothey @TGeorgeMD